enGene Therapeutics, Inc. (ENGN)
1.865
-0.08
(-3.87%)
USD |
NASDAQ |
Oct 05, 16:00
1.865
0.00 (0.00%)
After-Hours: 20:00
enGene Therapeutics Price to Book Value : 0.5427 for Oct. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 0.5645 |
| October 01, 2026 | 0.5762 |
| September 30, 2026 | 0.582 |
| September 29, 2026 | 0.5674 |
| September 28, 2026 | 0.5733 |
| September 25, 2026 | 0.5704 |
| September 24, 2026 | 0.5587 |
| September 23, 2026 | 0.582 |
| September 22, 2026 | 0.5965 |
| September 21, 2026 | 0.5704 |
| September 18, 2026 | 0.5558 |
| September 17, 2026 | 0.5558 |
| September 16, 2026 | 0.5558 |
| September 15, 2026 | 0.55 |
| September 14, 2026 | 0.5442 |
| September 11, 2026 | 0.5238 |
| September 10, 2026 | 0.5151 |
| September 09, 2026 | 0.5383 |
| September 08, 2026 | 0.5587 |
| September 04, 2026 | 0.5296 |
| September 03, 2026 | 0.5325 |
| September 02, 2026 | 0.55 |
| September 01, 2026 | 0.5398 |
| August 31, 2026 | 0.5354 |
| August 28, 2026 | 0.5311 |
| Date | Value |
|---|---|
| August 27, 2026 | 0.5558 |
| August 26, 2026 | 0.5674 |
| August 25, 2026 | 0.5442 |
| August 24, 2026 | 0.5267 |
| August 21, 2026 | 0.518 |
| August 20, 2026 | 0.5151 |
| August 19, 2026 | 0.5383 |
| August 18, 2026 | 0.5005 |
| August 17, 2026 | 0.4947 |
| August 14, 2026 | 0.4947 |
| August 13, 2026 | 0.4918 |
| August 12, 2026 | 0.4947 |
| August 11, 2026 | 0.5296 |
| August 10, 2026 | 0.5092 |
| August 07, 2026 | 0.5238 |
| August 06, 2026 | 0.5238 |
| August 05, 2026 | 0.5238 |
| August 04, 2026 | 0.5209 |
| August 03, 2026 | 0.5151 |
| July 31, 2026 | 0.5209 |
| July 30, 2026 | 0.4621 |
| July 29, 2026 | 0.4699 |
| July 28, 2026 | 0.4621 |
| July 27, 2026 | 0.4621 |
| July 24, 2026 | 0.4778 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Aurinia Pharmaceuticals, Inc. | 3.402 |
| Medicus Pharma Ltd. | -- |
| Xenon Pharmaceuticals, Inc. | 2.927 |
| Psyence Biomedical Ltd. | -- |
| Geron Corp. | 3.571 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0920 |
| Price | 1.865 |
| Earnings Yield | -111.5% |
| Market Cap | 124.98M |
| PEGY Ratio | -0.0920 |